Hepatitis B Immunoglobulin and Lamivudine Improve Hepatitis B–Related Outcomes After Liver Transplantation: Meta-Analysis Rohit Loomba, Ayana K. Rowley, Robert Wesley, Karen G. Smith, T. Jake Liang, Frank Pucino, Gyorgy Csako Clinical Gastroenterology and Hepatology Volume 6, Issue 6, Pages 696-700 (June 2008) DOI: 10.1016/j.cgh.2008.02.055 Copyright © 2008 AGA Institute Terms and Conditions
Figure 1 Selection of studies for meta-analysis regarding the effect of HBIG and LAM combination therapy vs HBIG monotherapy on HBV recurrence in patients receiving liver transplant. Clinical Gastroenterology and Hepatology 2008 6, 696-700DOI: (10.1016/j.cgh.2008.02.055) Copyright © 2008 AGA Institute Terms and Conditions
Figure 2 Meta-analysis regarding the effect of HBIG and LAM combination therapy vs HBIG monotherapy on HBV recurrence in patients receiving liver transplant. Clinical Gastroenterology and Hepatology 2008 6, 696-700DOI: (10.1016/j.cgh.2008.02.055) Copyright © 2008 AGA Institute Terms and Conditions